- Trials with a EudraCT protocol (7)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
7 result(s) found for: Scrotal.
Displaying page 1 of 1.
EudraCT Number: 2020-004630-38 | Sponsor Protocol Number: HydroceleAlkScler | Start Date*: 2021-05-20 | ||||||||||||||||
Sponsor Name:Region Jämtland/Härjedalen | ||||||||||||||||||
Full Title: Sclerotherapy for hydro and spermatoceles with 99.5% Ethanol, an open clinical multicenter dose escalation study, phase 2 | ||||||||||||||||||
Medical condition: Hydrocele and Spermatocele | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male | |||||||||||||||||
Trial protocol: SE (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-002945-41 | Sponsor Protocol Number: 78464317 | Start Date*: 2020-09-24 | ||||||||||||||||||||||||||
Sponsor Name:Lone Nikolajsen | ||||||||||||||||||||||||||||
Full Title: The use of intraoperative methadone in children undergoing open urological surgery | ||||||||||||||||||||||||||||
Medical condition: Postoperative pain in children undergoing open urological surgery | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male | |||||||||||||||||||||||||||
Trial protocol: DK (Prematurely Ended) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2019-003792-19 | Sponsor Protocol Number: FOS-PROST-001 | Start Date*: 2021-03-04 |
Sponsor Name:Hospital Universitari Mutua Terrassa | ||
Full Title: Fosfomycin as an oral alternative treatment for acute bacterial prostatitis due to multi-drug resistant Escherichia coli. Pilot study | ||
Medical condition: Acute bacterial prostatitis due to multi-drug resistant Escherichia coli | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2009-011789-26 | Sponsor Protocol Number: IELSG30 | Start Date*: 2010-01-25 | |||||||||||
Sponsor Name:IELSG-International Extranodal Lymphoma Study Group | |||||||||||||
Full Title: A phase II study of R-CHOP with intensive CNS prophylaxis and scrotal irradiation in patients with primary testicular diffuse large B-cell lymphoma | |||||||||||||
Medical condition: primary testicular lymphoma diffuse large B-cell | |||||||||||||
|
|||||||||||||
Population Age: In utero, Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-001258-25 | Sponsor Protocol Number: MK8962-031-00 | Start Date*: 2012-11-29 | |||||||||||
Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. | |||||||||||||
Full Title: A phase III, multi-center, open label, uncontrolled trial to investigate the efficacy and safety of MK-8962 (corifollitropin alfa) in combination with human Chorionic Gonadotropin (hCG) in inducing... | |||||||||||||
Medical condition: Hypogonadotropic hypogonadism (HH) in males may result from either absent or inadequate gonadotropin-releasing hormone (GnRH) secretion by the hypothalamus or failure of pituitary gonadotropin secr... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: DE (Completed) ES (Completed) IT (Completed) GB (Completed) PL (Completed) Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-001199-23 | Sponsor Protocol Number: ICR-CTSU/2014/10048 | Start Date*: 2016-10-11 | |||||||||||
Sponsor Name:The Institute of Cancer Research | |||||||||||||
Full Title: InPACT - International Penile Advanced Cancer Trial (International Rare Cancer Initiative) | |||||||||||||
Medical condition: Locally advanced squamous carcinoma of the penis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-011617-25 | Sponsor Protocol Number: V503-002 | Start Date*: 2009-10-16 |
Sponsor Name:MSD Finland Oy | ||
Full Title: A Study to Demonstrate Immunogenicity, Tolerability, and Manufacturing Consistency of a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine Administered in Preadolescents an... | ||
Medical condition: Cervical Cancer | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: FI (Completed) BE (Completed) AT (Completed) SE (Completed) ES (Completed) PL (Completed) Outside EU/EEA | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
